FDA Investigates Fungal Infection Associated with Tennessee Compounding Pharmacy

The U.S. Food and Drug Administration, Centers for Disease Control and Prevention and Tennessee Board of Pharmacy are investigating seven adverse events reported from steroid injections compounded by Main Street Family Pharmacy in Newbern, Tenn.

Advertisement

All reported patients received 80 mg injections of preservative-free methylprednisolone acetate, and at least one injection appears to be fungal.

The FDA recommends all healthcare providers refrain from administering any Main Street sterile products and quarantining them until further notice.

More Articles on Anesthesia:
MEDNAX Acquires Anesthesia Specialists of Houston
Survey: 53% Anesthesiologists Struggle With Pulse Oximetry Sensor Readings
ASA Supports Congress in Expanding Anesthesiologists’ HIT Exemptions

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Anesthesia

  • The Morgantown-based West Virginia University School of Nursing is increasing its Doctor of Nursing Practice Nurse Anesthetist program from 15…

Advertisement

Comments are closed.